Home > PE Ratio > BLISS GVS PHARMA

BLISS GVS PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of BLISS GVS PHARMA is 19.18.

Share Price ₹207.4Feb 10,2026
Market Cap ₹2,194.3 Cr
Earnings-TTM₹114.4 CrTTM-Consolidated Results
Price/Earnings19.18xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BLISS GVS PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BLISS GVS PHARMA is calculated as :

Current Market Cap [ ₹2,194.3 Cr] as on Feb 10,2026

(/) Earnings [ ₹114.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 19.18x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BLISS GVS PHARMA , the investors are currently willing to pay 19.18 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BLISS GVS PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BLISS GVS PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of BLISS GVS PHARMA


PE Ratio Performance Analysis for BLISS GVS PHARMA

- BLISS GVS PHARMA 's latest p/e ratio is 19.18x.

- BLISS GVS PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 21.74x.

- BLISS GVS PHARMA 's operated at median p/e ratio of 14.86x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BLISS GVS PHARMA 's p/e ratio peaked in Mar2022 at 53.04x.

- BLISS GVS PHARMA 's p/e ratio hit its five-year low in Mar2023 of 10.47x.


How does BLISS GVS PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BLISS GVS PHARMA 114.3819.182,194.3
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4037.24409,698.0
DIVIS LABORATORIES LTD2,485.0065.94163,866.0
CIPLA LTD4,544.7023.85108,412.0
TORRENT PHARMACEUTICALS LTD2,140.0064.51138,062.0
DR REDDYS LABORATORIES LTD5,508.7019.03104,805.0
MANKIND PHARMA LTD1,796.6547.6185,533.2
ZYDUS LIFESCIENCES LTD4,933.9018.0989,273.1
LUPIN LTD4,347.5323.17100,736.0
AUROBINDO PHARMA LTD3,513.2018.5565,186.3
ABBOTT INDIA LTD1,508.9538.4758,041.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BLISS GVS PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.09x
Max industry PE 65.94x
Median industry PE 23.85x
Average industry PE 34.15x



You may also like the below Video Courses